Burden of venous thromboembolism in patients with pancreatic cancer
Author:
Open Access
- 21 May 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (19) , 2325-2340
Abstract
Burden of venous thromboembolism in patients with pancreatic cancerKeywords
This publication has 75 references indexed in Scilit:
- Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-AnalysisPLOS Medicine, 2012
- Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancerThrombosis and Haemostasis, 2011
- Serum Platelet Factor 4 Is an Independent Predictor of Survival and Venous Thromboembolism in Patients with Pancreatic AdenocarcinomaCancer Epidemiology, Biomarkers & Prevention, 2010
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsAnnals of Oncology, 2007
- Venous Thromboembolism in the Outpatient SettingArchives of internal medicine (1960), 2007
- Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day PeriodClinical and Applied Thrombosis/Hemostasis, 2006
- High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patientsEuropean Journal of Cancer, 2006
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002